Related Experiment Video
Updated: Jul 13, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
[Biologic therapy: current and future applications in oncology]
1Servicio de Oncología Médica, Hospital Universitario de la Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España. aleixprat@yahoo.es
Abstract:
Nowadays, cancer is the first cause of death in the developed world, accounting for 94,000 yearly deaths in Spain. In recent years, advances in the field of molecular cancer biology and cancer therapy have identified a number of potential target molecules that play a critical role in the complex malignant cell transformation process. Since the approval of the first molecularly targeted drug imatinib in 2001, hundreds of novel agents are being investigated as monotherapy or in combination with chemotherapy and/or radiotherapy for the treatment of cancer of the breast, colon and rectum, lung, kidney, and head and neck, among others. Interestingly, molecularly targeted agents are becoming the new standard of care in some malignances such as renal-cell carcinoma and chronic myeloid leukemia. Future research on molecularly targeted therapies will focus on the identification of new drugs and drug targets, improved selection of tumors sensitive to these drugs, and the rational design and optimization of combination therapies.
Insights
Molecularly targeted therapies offer new hope for cancer treatment, becoming a standard of care for some cancers. Future research aims to discover new drugs, targets, and optimize combination therapies for better patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Context:
- Cancer remains a leading cause of death globally and in Spain, with significant mortality.
- Recent advancements in molecular cancer biology have identified critical targets for therapeutic intervention.
- The development of molecularly targeted drugs has revolutionized cancer treatment approaches.
Purpose:
- To review the progress and future directions of molecularly targeted therapies in oncology.
- To highlight the role of molecularly targeted agents in treating various cancers.
- To discuss the potential of combination therapies and personalized medicine in cancer care.
Summary:
- Since 2001, numerous molecularly targeted agents have been developed and are under investigation for various cancers.
- These targeted therapies are increasingly becoming the standard of care for specific malignancies like renal-cell carcinoma and chronic myeloid leukemia.
- Research is focusing on identifying new drug targets, improving patient selection for targeted treatments, and optimizing combination strategies.
Impact:
- Molecularly targeted therapies represent a paradigm shift in cancer treatment, moving towards precision medicine.
- These agents offer improved efficacy and potentially reduced side effects compared to traditional chemotherapy.
- Continued research promises further advancements in drug discovery, patient stratification, and combination treatment regimens for enhanced cancer management.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

